Kenneth Schwartz
Family Medicine · Malta, NYNPI 1942226857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $602 and has fallen 69.7% since, to $182 in 2023.
Across 128 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$334
- Takeda Pharmaceuticals U.S.A., Inc.$247
- Lilly USA, LLC$228
- Boehringer Ingelheim$225
- AbbVie$148
- Circassia Inc.$123
- plus $740 from 20 others
What the payments were for
- Food & beverage$2,045100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $334 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $247 |
| Lilly USA, LLC | 14 | $228 |
| Boehringer Ingelheim | 12 | $225 |
| AbbVie(2 entities) | 9 | $148 |
| Circassia Inc. | 12 | $123 |
| GSK | 7 | $116 |
| Amgen(2 entities) | 6 | $95 |
| Amarin Pharma, Inc. | 5 | $80 |
| Currax Pharmaceuticals LLC | 5 | $70 |
| Merck | 3 | $43 |
| Pfizer | 3 | $43 |
| AstraZeneca | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Eisai Inc. | 1 | $25 |
| Genentech USA, Inc. | 2 | $24 |
| Dexcom, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| IBSA Pharma Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Mannkind Corporation | 1 | $12 |
How this compares
$2,045 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.
Other family medicine in Malta
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
- James NorthGlens Falls$186K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.